Literature DB >> 22581853

Negative feedback regulation of antigen receptors through calmodulin inhibition of E2A.

Jiyoti Verma-Gaur1, Jannek Hauser, Thomas Grundström.   

Abstract

Signaling from the BCR is used to judge Ag-binding strengths of the Abs of B cells. BCR signaling enables the selection for successive improvements in the Ag affinity over an extremely broad range of affinities during somatic hypermutation. We show that the mouse BCR is subject to general negative feedback regulation of the receptor proteins, as well as many coreceptors and proteins in signal pathways from the receptor. Thus, the BCR can downregulate itself, which can enable sensitive detection of successive improvements in the Ag affinity over a very large span of affinities. Furthermore, the feedback inhibition of the BCR signalosome and most of its proteins, as well as most other regulations of genes by BCR stimulation, is to a large extent through inhibition of the transcription factor E2A by Ca(2+)/calmodulin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581853     DOI: 10.4049/jimmunol.1103105

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.

Authors:  Helen E Speedy; Maria Chiara Di Bernardo; Georgina P Sava; Martin J S Dyer; Amy Holroyd; Yufei Wang; Nicola J Sunter; Larry Mansouri; Gunnar Juliusson; Karin E Smedby; Göran Roos; Sandrine Jayne; Aneela Majid; Claire Dearden; Andrew G Hall; Tryfonia Mainou-Fowler; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; David J Allsup; James R Bailey; Guy Pratt; Chris Pepper; Chris Fegan; Richard Rosenquist; Daniel Catovsky; James M Allan; Richard S Houlston
Journal:  Nat Genet       Date:  2013-12-01       Impact factor: 38.330

Review 2.  Helix-Loop-Helix Proteins in Adaptive Immune Development.

Authors:  Megan Aubrey; Zachary J Warburg; Cornelis Murre
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

3.  Interference with pre-B-cell receptor signaling offers a therapeutic option for TCF3-rearranged childhood acute lymphoblastic leukemia.

Authors:  A van der Veer; V H J van der Velden; M E Willemse; P G Hoogeveen; E F Petricoin; H B Beverloo; G Escherich; M A Horstmann; R Pieters; M L den Boer
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.